EUVIMEDEUVIMED entdecken
Crossref

Opioid Usage Following Oculoplastic Procedures

Frank Mei iD, Victoria Garfinkel, Matthew Petroll, Ronald Mancini

Aesthetic Surgery Journal · 2024

DOI: 10.1093/asj/sjae014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aesthetic Surgery Journal, 2024. Verfasst von Frank Mei und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Analgesics, Opioid, Postoperative Pain, Tramadol. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

With the rising toll of the opioid crisis, oculoplastic surgeons have been looking at methods to decrease opioid prescription.

Objectives

The aim of this study was to identify factors that correlate with opioid usage after oculoplastic surgery.

Methods

This was a prospective study conducted at University of Texas Southwestern. All patients who underwent an oculoplastic procedure were eligible for inclusion. Patients enrolled were provided 20 tablets of tramadol 50 mg, to take 1 tablet every 6 hours as needed for pain. At their postoperative week 1 appointment, participants had the remaining number of unused opioid tablets counted. The number of tablets taken were calculated by subtracting the remaining number of tablets from the original prescribed amount.

Results

A total of 310 patients were enrolled in our study. Of these, 129 patients met the inclusion criteria. There was a statistically significant difference in the number of tramadol tablets taken between procedures for upper eyelids, lower eyelids, and both eyelids (P < .01). There were no statistically significant differences in tramadol usage when comparing procedures on eyelids with orbit procedures(P = .30), cosmetic with noncosmetic procedures (P = .52), males with females (P = .87), or patients naive to oculoplastic procedures with those undergoing reoperation (P = .58). Longer procedures were correlated with greater tramadol usage (R = 0.28, P < .01).

Conclusions

This is the first study in the literature that has objectively quantified opioid usage after oculoplastic surgery in a prospective manner. Procedures that involve both upper and lower eyelids simultaneously and longer procedures resulted in higher opioid use. Orbital procedures, cosmetic procedures, sex, and procedural naivety were not found to be associated with higher opioid usage. Level of Evidence: 4

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidPostoperative PainTramadolHumansMaleFemaleProspective StudiesMiddle AgedAdultAgedYoung AdultEyelidsTexasTime FactorsDrug PrescriptionsPractice Patterns, Physicians'

Substanzen

Analgesics, OpioidTramadol

Autor:innen und Institutionen

ORCID-Profile: Frank Mei

Zitieren

APA

Mei, F., Garfinkel, V., Petroll, M., & Mancini, R. (2024). Opioid Usage Following Oculoplastic Procedures. Aesthetic Surgery Journal. https://doi.org/10.1093/asj/sjae014

Vancouver

Mei F, Garfinkel V, Petroll M, Mancini R. Opioid Usage Following Oculoplastic Procedures. Aesthetic Surgery Journal. 2024. doi:10.1093/asj/sjae014

BibTeX
@article{Mei2024,
  author = {Mei, Frank and Garfinkel, Victoria and Petroll, Matthew and Mancini, Ronald},
  title = {Opioid Usage Following Oculoplastic Procedures},
  journal = {Aesthetic Surgery Journal},
  year = {2024},
  doi = {10.1093/asj/sjae014}
}
Kostenlos starten →